510(k) K841245

ENZYGNOST ANTIHERPES SIMPLEX VIRUS by Behring Diagnostics, Inc. — Product Code GQO

K841245 is an FDA 510(k) premarket notification submitted by Behring Diagnostics, Inc. for the device "ENZYGNOST ANTIHERPES SIMPLEX VIRUS". The FDA issued a decision of Substantially Equivalent on November 5, 1985. The device falls under product code GQO (Antisera, Cf, Herpesvirus Hominis 1,2), a Class II device regulated under 21 CFR 866.3305. Behring Diagnostics, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 5, 1985
Date Received
March 23, 1984
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antisera, Cf, Herpesvirus Hominis 1,2
Device Class
Class II
Regulation Number
866.3305
Review Panel
MI
Submission Type